APA (7th ed.) Citation

Egeberg, A., Merola, J. F., Schäkel, K., Puig, L., Mahar, P. D., Wang, I. Y., . . . Griffiths, C. E. M. (2022). Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes. Frontiers in medicine, 9, . https://doi.org/10.3389/fmed.2022.1092688

Chicago Style (17th ed.) Citation

Egeberg, Alexander, Joseph F. Merola, Knut Schäkel, Luis Puig, Patrick D. Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster, and Christopher E. M. Griffiths. "Efficacy of Ixekizumab in Patients with Moderate-to-severe Plaque Psoriasis and Prediabetes or Type 2 Diabetes." Frontiers in Medicine 9 (2022). https://doi.org/10.3389/fmed.2022.1092688.

MLA (9th ed.) Citation

Egeberg, Alexander, et al. "Efficacy of Ixekizumab in Patients with Moderate-to-severe Plaque Psoriasis and Prediabetes or Type 2 Diabetes." Frontiers in Medicine, vol. 9, 2022, https://doi.org/10.3389/fmed.2022.1092688.